Botulinum Toxin Type A Attenuates Apoptosis in Human Dermal Microvascular Endothelial Cells Exposed to an In Vitro Model of Ischemia/Reperfusion Injury.
Abstract
[BACKGROUND] Botulinum toxin type A (BTXA) has been reported to increase survival of critically ischemic skin flaps; however, the effect of BTXA in human dermal microvascular endothelial cells (HDMECs) remains to be investigated. This study aimed to investigate the protective effect of BTXA in HDMECs exposed to an in vitro model of ischemia/reperfusion injury.
[METHODS] HDMECs were isolated from human upper eyelid tissue and were randomly divided into 3 groups: 1.
[CONTROL GROUP] culture under normoxic conditions (95% air and 5% CO); 2. hypoxia/reoxygenation (H/R) group: culture in a hypoxic incubator (94% N + 5% CO + 5% O) for 8 hours, followed by culture in saturated aerobic culture medium for 24 hours; and 3. BTXA group: treatment with BTXA for 12 hours before exposure to hypoxic conditions. Flow cytometry was used to analyze the apoptosis of HDMECs, and western blotting was used to detect the expression of apoptosis-related proteins.
[RESULTS] H/R leads to severe injury in HDMECs, as evidenced by an increase in the percentage of apoptosis and an increase in expression of apoptosis-related proteins (Bax, cleaved-caspase-3, and cytochrome C). Moreover, H/R results in a decrease in expression of anti-apoptotic protein (Bcl-2), which can be significantly attenuated with BTXA treatment.
[CONCLUSION] BTXA protects against apoptosis in HDMECs exposed to an in vitro model of H/R-induced injury.
[METHODS] HDMECs were isolated from human upper eyelid tissue and were randomly divided into 3 groups: 1.
[CONTROL GROUP] culture under normoxic conditions (95% air and 5% CO); 2. hypoxia/reoxygenation (H/R) group: culture in a hypoxic incubator (94% N + 5% CO + 5% O) for 8 hours, followed by culture in saturated aerobic culture medium for 24 hours; and 3. BTXA group: treatment with BTXA for 12 hours before exposure to hypoxic conditions. Flow cytometry was used to analyze the apoptosis of HDMECs, and western blotting was used to detect the expression of apoptosis-related proteins.
[RESULTS] H/R leads to severe injury in HDMECs, as evidenced by an increase in the percentage of apoptosis and an increase in expression of apoptosis-related proteins (Bax, cleaved-caspase-3, and cytochrome C). Moreover, H/R results in a decrease in expression of anti-apoptotic protein (Bcl-2), which can be significantly attenuated with BTXA treatment.
[CONCLUSION] BTXA protects against apoptosis in HDMECs exposed to an in vitro model of H/R-induced injury.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 시술 | botulinum toxin
|
보툴리눔독소 주사 | dict | 2 | |
| 시술 | microvascular
|
미세수술 | dict | 2 | |
| 해부 | upper eyelid
|
눈꺼풀 | dict | 1 |
MeSH Terms
Apoptosis; Botulinum Toxins, Type A; Cell Hypoxia; Cells, Cultured; Endothelium, Vascular; Eyelids; Female; Flow Cytometry; Humans; Reperfusion Injury
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Local therapeutic strategies for neurocutaneous dysesthesia: from capsaicin to cannabinoids.
- Comparative efficacy of intralesional therapies for keloid scars: a network meta-analysis.
- Endodontic implications of hypercementosis: A systematic review of anatomical challenges and therapeutic strategies.
- Adverse neurological events following botulinum toxin type A: A case series of post-injection seizures and paralysis.
- Decreased utilization of component separation techniques over time in complex abdominal wall reconstruction following introduction of preoperative botulinum toxin A.